Back to Search Start Over

Spot Specimen Testing With GeneXpert® MTB/RIF Results In More Complete TB Diagnostic Results Than Morning Specimens

Authors :
Bouke C. de Jong
Leen Rigouts
Gildas Agodokpessi
Dissou Affolabi
Schadrac C. Agbla
Merlin Fandohan
A.P. Wachinou
Faridath Massou
Publication Year :
2021
Publisher :
Research Square Platform LLC, 2021.

Abstract

Background: The diagnosis of Tuberculosis (TB) using smear microscopy has been based on testing 2 specimens: one spot and one early morning sputum. Recently, the World Health Organization (WHO) recommended to replace, whenever possible, microscopy with GeneXpert® MTB/RIF performed on a single specimen. However, as the bacterial load is higher in early morning specimens than in spot specimens, one could expect lower sensitivity of GeneXpert® MTB/RIF performed only on spot specimens. In this study, we compared results of GeneXpert® MTB/RIF on spot specimens versus early morning specimens, under programmatic conditions in Cotonou, Benin. Methods: From June to September 2018, all sputa received from presumptive TB patients at the Supranational Reference Laboratory for Tuberculosis of Cotonou were included in the study. From each patient, two specimens were collected (one spot and one early morning) and GeneXpert® MTB/RIF was performed on both specimens. Results: In total, 886 participants were included in the study, of whom 737 provided both sputa and 149 (16.8%) gave only the spot specimen. For the 737 participants who provided both sputa, GeneXpert® MTB/RIF was positive for both specimens in 152 participants; for three participants GeneXpert® MTB/RIF was positive on spot specimen but negative on morning specimen while for another three, the test was positive on morning specimen but negative on spot specimen. The overall percentage of agreement was excellent (99.2%) with a very positive and negative percent agreement greater than 98%.Conclusions: For TB diagnosis under programmatic conditions in Cotonou, GeneXpert® MTB/RIF in spot specimens gave similar results with the test in morning specimens. Performing GeneXpert® MTB/RIF in both specimens did not significantly increase the number of cases detected. To avoid losing patients from the diagnostic cascade, it is preferable to test sputa produced at the time of visit.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........1e7d9254088fafc4257ad955ea02bf7e
Full Text :
https://doi.org/10.21203/rs.3.rs-777546/v1